Table 1. Expression of HER2, pHER1, pHER2 and pHER3 in tumors with or without Src expressed at the plasma membrane.

	Tumors without membrane Src (n = 110)	Tumors with membrane Src (n = 149)
HER2-positive	1.8% (n = 2)	12.8% (n = 19)
pHER1	13.6% (n = 15)	21.5% (n = 32)
pHER2	7.2% (n = 8)	19.5% (n = 29)
pHER3	9% (n = 10)	20% (n = 30)